Dr. Minzhao Lin | Biochemistry | Best Researcher Award

Dr. Minzhao Lin | Biochemistry | Best Researcher Award

Dr. Minzhao Lin , Biochemistry,  Lecturer at Dezhou University, China

Dr. Minzhao Lin is a dedicated biomedical researcher and currently serves as a Lecturer at Dezhou College, China. With a Ph.D. in Biology and Medicine from Sun Yat-sen University, he has established himself in the interdisciplinary fields of nanomedicine, cancer immunotherapy, and tumor microenvironment modulation. He has authored over 24 publications, with 7 as co-first or corresponding author, and actively contributed to national-level research projects focusing on advanced drug delivery systems. Skilled in nanocarrier design, cellular assays, animal modeling, and analytical techniques, Dr. Lin bridges materials science with biomedical innovation. As a project group administrator, he successfully oversaw key grant applications and cross-disciplinary collaborations. His research emphasizes innovation in cancer therapy using hierarchical and responsive nanoplatforms. Dr. Lin is passionate about translational medicine and continuously seeks to advance therapies that can impact clinical outcomes in oncology and beyond.

Professional Profile : 

Google Scholar

Orcid

Scopus 

Summary of Suitability for Award:

Dr. Minzhao Lin stands out as a strong candidate for the “Best Researcher Award” due to his outstanding interdisciplinary contributions to cancer nanomedicine and immunotherapy. With a Ph.D. from Sun Yat-sen University and over 24 peer-reviewed publications (7 as co-first/corresponding author), he has demonstrated deep expertise in designing stimuli-responsive nanocarriers, microneedle drug delivery systems, and immune-modulatory therapeutic platforms. His research addresses real-world biomedical challenges like tumor drug resistance and targeted delivery across the blood-brain barrier, which are of high clinical relevance. He has successfully co-led multiple nationally funded projects, managed high-level lab operations, and contributed to grant proposals, manuscript drafting, and final reporting—demonstrating leadership, innovation, and research management capabilities. His work is published in top-tier journals like Nature Communications, Biomaterials, and ACS Applied Materials & Interfaces—signaling international recognition and scholarly impact. Dr. Minzhao Lin exemplifies the criteria for the “Best Researcher Award”, given his innovative research, publication record, leadership in key national projects, and substantial contributions to translational cancer nanomedicine. His work is not only academically robust but also holds significant potential for clinical applications. He is highly deserving of this recognition.

🎓Education:

Minzhao Lin pursued his academic journey through prestigious Chinese institutions. He earned his Ph.D. in Biology and Medicine (2020–2024) from the College of Materials Science and Engineering at Sun Yat-sen University, Guangzhou, China. His doctoral work focused on hierarchical nanomedicine for cancer immunotherapy. Prior to that, he completed his M.Sc. in Plant Prevention and Biomaterials (2017–2020) at South China Agricultural University, where he built foundational expertise in biomaterials and pathogen defense. His undergraduate degree in Environmental Science (2013–2017), also from South China Agricultural University, was marked by outstanding academic performance, with a GPA of 4.15/5 and a rank of 5th out of 330 students. This diverse educational foundation in environmental science, biomaterials, and biomedicine has equipped Dr. Lin with a unique interdisciplinary perspective vital for innovation in nanomedicine and cancer research.

🏢Work Experience:

Dr. Minzhao Lin serves as a Lecturer at Dezhou College, where he engages in teaching and scientific research. During his doctoral studies at Sun Yat-sen University (2020–2024), he managed national research projects, coordinated multi-institutional collaborations, and played a central role in nanodrug development. As a Project Group Administrator, he handled proposal drafting, procurement, lab safety, and team management. His technical expertise encompasses synthesis of polymeric/lipid nanocarriers, in vitro/in vivo biological assessments, and advanced imaging and analysis. Dr. Lin has worked extensively on microneedle-based drug delivery systems for cancer immunotherapy and contributed significantly to the completion of NSFC and Guangzhou Municipal R&D projects. He has also published in high-impact journals and participated in project finalization and grant reporting. His scientific rigor and leadership skills make him a valuable contributor to biomedical innovation and higher education.

🏅Awards: 

Dr. Minzhao Lin has earned significant recognition for his contributions to biomedical research, particularly in the fields of nanomedicine and cancer immunotherapy. His scholarly impact is reflected in his role as co-first or corresponding author on seven high-impact publications and as co-author on an additional 17 papers in prestigious journals such as Nature Communications, Biomaterials, ACS Applied Materials & Interfaces, and Advanced Science. As a key contributor to two nationally funded research projects under the National Natural Science Foundation of China (NSFC) and the Guangzhou Municipal Key R&D Program, Dr. Lin successfully led the technical development and final reporting phases. His leadership as project group administrator resulted in the successful completion and approval of multiple major research grants. Through his innovative work on nanocarrier systems and microneedle-based delivery platforms, Dr. Lin has built a reputation for scientific excellence and research innovation, earning him institutional and collaborative accolades in China’s biomedical research community.

🔬Research Focus:

Minzhao Lin’s research centers on the development of hierarchical targeted nanomedicine for cancer immunotherapy . His work bridges materials science and oncology, designing multifunctional polymeric and lipid-based carriers that can modulate the tumor microenvironment, overcome drug resistance, and improve immune response activation. Key themes include ROS regulation, co-delivery of therapeutics, metabolism reprogramming, and stimuli-responsive systems. He has also advanced microneedle platforms and flocculant-based delivery technologies for therapeutic and environmental applications. Dr. Lin’s goal is to achieve precise and efficient drug delivery, especially in hard-to-treat cancers such as triple-negative breast cancer and glioma, through multimodal strategies. His collaborative efforts in integrating imaging, immunomodulation, and nanocarrier design reflect a holistic approach to personalized medicine and translational research.

Publication Top Notes:

1.Title: Surgical tumor-derived photothermal nanovaccine for personalized cancer therapy and prevention
Citations: 73

2.Title: GSH‐Responsive metal–organic framework for intratumoral release of NO and IDO inhibitor to enhance antitumor immunotherapy
Citations: 64

3.Title: Nanodrug augmenting antitumor immunity for enhanced TNBC therapy via pyroptosis and cGAS-STING activation
Citations: 56

4.Title: Floatable magnetic aerogel based on alkaline residue used for the convenient removal of heavy metals from wastewater
Citations: 41

5.Title: Transparent floatable magnetic alginate sphere used as photocatalysts carrier for improving photocatalytic efficiency and recycling convenience.
Citations: 34

6.Title: Nanodrug regulates lactic acid metabolism to reprogram the immunosuppressive tumor microenvironment for enhanced cancer immunotherapy
Citations: 33

7.Title: Nanodrugs incorporating LDHA siRNA inhibit M2-like polarization of TAMs and amplify autophagy to assist oxaliplatin chemotherapy against colorectal cancer
Citations: 26

8.Title: Tumor acidity-activatable macromolecule autophagy inhibitor and immune checkpoint blockade for robust treatment of prostate cancer
Citations: 23

9.Title: Retinol-binding protein-hijacking nanopolyplex delivering siRNA to cytoplasm of hepatic stellate cell for liver fibrosis alleviation
Citations: 23

10.Title: Nanodrug simultaneously regulates stromal extracellular matrix and glucose metabolism for effective immunotherapy against orthotopic pancreatic cancer
Citations: 23

 

Dr. Satyen Kumar Das | Chemical Engineering | Best Researcher Award

Dr. Satyen Kumar Das | Chemical Engineering | Best Researcher Award

Dr. Satyen Kumar Das , Chemical Engineering ,  Chief General Manager at Indian Oil Corporation Limited, R&D Centre , India

Dr. Satyen Kumar Das is a distinguished Chemical Engineer and Chief General Manager at Indian Oil R&D Centre, leading the Refining Technology domain. Since joining Indian Oil in 1995, he has contributed nearly 30 years of cutting-edge research, commercialization, and troubleshooting in petroleum refining, sustainability, and circularity. He is recognized for pioneering indigenous technologies such as Ind-Coker, Needle Coke, INDMAX, and INDEcoP2F, significantly contributing to India’s energy innovation and self-reliance. With over 200 patents (144 granted globally) and 94 technical publications, his work bridges research and industry application seamlessly. Dr. Das is known for driving initiatives in crude-to-chemicals, bio-refinery, waste-to-energy, and CO₂ valorization. He has led the successful deployment of several commercial-scale processes and continues to champion green and circular technologies for a sustainable energy future. His leadership and innovation have earned him several prestigious national accolades, making him a key figure in India’s refining research landscape.

Professional Profile : 

Google Scholar 

Scopus

Summary of Suitability for Award:

Dr. Satyen Kumar Das is a seasoned chemical engineering researcher with nearly three decades of experience at the forefront of petroleum refining technology. As Chief General Manager at Indian Oil R&D, he has spearheaded groundbreaking innovations in residue upgradation, crude-to-chemicals, plastic circularity, and CO₂ valorization—making significant contributions toward energy sustainability and circular economy. He has led the commercialization of six major technologies and supported the operation of four commercial plants. With 210 patents filed (144 granted across multiple jurisdictions including the US, Europe, and India) and 94 journal and conference publications, his research has had both academic impact and industrial translation. Dr. Das has been honored by multiple national bodies, including the Ministry of Petroleum & Natural Gas (GoI), DSIR, and AIMA, for innovations like INDMAX, Needle Coke Technology, and IV- IZOMaxCATR. His work bridges fundamental research, applied technology, and commercial deployment, positioning him as a pioneer in refining technology and sustainable process development. Dr. Satyen Kumar Das exemplifies the qualities sought for the “Best Researcher Award”—originality, industrial relevance, academic excellence, and societal impact. His contributions have not only advanced the frontiers of petroleum research but also addressed critical environmental and sustainability challenges. He is an exceptional candidate for this prestigious recognition.

🎓Education:

Dr. Satyen Kumar Das holds a Ph.D. in Chemical Engineering from the Indian Institute of Technology (IIT) Delhi, where he specialized in advanced refining technologies. He earned his M.Tech in Chemical Engineering from IIT Kanpur, where he developed a strong foundation in process design, catalysis, and fuel technology. He began his academic journey with a B.Tech in Chemical Engineering from Calcutta University, where he demonstrated academic brilliance and curiosity for applied research. His academic path through premier institutions helped him cultivate expertise across petroleum refining, catalysis, process engineering, and materials chemistry. The rigorous and interdisciplinary training he received has been instrumental in his successful translation of R&D projects into commercial technologies. His educational background also laid the groundwork for his future role as a technocrat and innovator in India’s petroleum industry. His continuous learning mindset remains central to his leadership at Indian Oil R&D Centre.

🏢Work Experience:

Dr. Das began his professional journey at Indian Oil’s R&D Centre in 1995. Over nearly three decades, he has grown to become Chief General Manager, heading Refining Technology. From 1995 to 2013, he played a pivotal role in developing processes such as INDMAX, INDALIN, DIST-Extra, and MAXLIN. His technical services and troubleshooting expertise in FCC/RFCC/INDMAX made a significant impact on operational efficiency. From 2014 onward, he has been spearheading key initiatives including Ind-Coker, Crude to Chemicals, Needle Coke, and INDEcoP2F (plastic circularity). He has led technology commercialization efforts, driving innovations like MMO catalysts, Octamax, and IV- IZOMaxCATR. Dr. Das has overseen deployment of over 4 commercial technologies and filed over 210 patents, marking his influence on both national and global energy platforms. His forward-looking leadership also covers futuristic domains such as bio-refinery, CO₂ valorization, and advanced carbon materials, ensuring India’s alignment with energy sustainability goals.

🏅Awards: 

Dr. Satyen Kumar Das has been honored with numerous prestigious awards for his innovation in petroleum refining. He received the NPMP Award for INDMAX and Needle Coke technologies 🧪, and the DSIR Award for INDMAX commercialization 🛢️. The AIMA Award recognized his breakthroughs in R&D and AI integration 🤖. His energy-efficient, eco-friendly technologies, including Anode Grade Coker and IV- IZOMaxCATR, won accolades from the Ministry of Petroleum & Natural Gas (MOP&NG) . Notable recognitions include the Innovation Awards (2019-20, 2022-23, 2023-24) for technologies such as Delayed Coker and INDEcoP2F ♻️. In 2025, he was also awarded the JEWEL OF INDIA 🏅 for his outstanding contributions to petroleum science. These honors are a testament to his commitment to technological excellence, sustainability, and Atmanirbhar Bharat in the energy domain. His award-winning innovations have significantly strengthened India’s refining and circular economy capabilities.

🔬Research Focus:

Dr. Das’s research centers on refining technology innovation, petroleum residue upgrading, and sustainable energy solutions. He focuses on developing high-efficiency catalytic processes such as INDMAX and Ind-Coker 🛢️. His work emphasizes crude-to-chemicals conversion, light olefins production, and high-octane fuel blending components like Octamax and AmyleMax 🔄. A pioneer in circular economy research, he spearheads INDEcoP2F for plastic-to-fuel transformation ♻️. He also works on CO₂ valorization, specialty chemical synthesis, and advanced carbon materials 🌱. With a forward-looking vision, Dr. Das has launched multiple initiatives in bio-refinery, waste-to-energy, and indigenous catalyst development 🔋. His research integrates sustainability, process intensification, and commercial viability, shaping India’s roadmap towards energy security and carbon neutrality. Through 210+ patents and 94 publications, he bridges academic research and industrial application, ensuring innovation meets implementation. His focus continues to align with global trends in green refining and circular chemical engineering.

Publication Top Notes:

1. Multi stage selective catalytic cracking process and a system for producing high yield of middle distillate products from heavy hydrocarbon feedstocks

Authors: D Bhattacharyya, AK Das, AV Karthikeyani, SK Das, P Kasliwal, M Santra, …

Citations: 65

2. CO-hydrogenation of syngas to fuel using silica supported Fe–Cu–K catalysts: Effects of active components

Authors: SK Das, S Majhi, P Mohanty, KK Pant

Citations: 42

3. Process for catalytic cracking of petroleum based feed stocks

Authors: S Mandal, S Kumarshah, D Bhattacharyya, VLN Murthy, AK Das, S Singh, …

Citations: 41

4. CO-hydrogenation over silica supported iron based catalysts: Influence of potassium loading

Authors: SK Das, P Mohanty, S Majhi, KK Pant

Citations: 40

5. Upgradation of undesirable olefinic liquid hydrocarbon streams

Authors: AK Das, S Mandal, S Ghosh, D Bhattacharyya, GS Mishra, JK Dixit, …

Citations: 38

6. Stabilized dual zeolite single particle catalyst composition and a process thereof

Authors: MP Kuvettu, SK Ray, G Ravichandran, V Krishnan, SK Das, S Makhija, …

Citations: 31

7. Molecular-level structural insight into clarified oil by nuclear magnetic resonance (NMR) spectroscopy: estimation of hydrocarbon types and average structural parameters

Authors: S Mondal, A Yadav, R Kumar, V Bansal, SK Das, J Christopher, GS Kapur

Citations: 29

8. Process for simultaneous cracking of lighter and heavier hydrocarbon feed and system for the same

Authors: S Subramani, D Bhattacharyya, R Manna, SK Das, T Sarkar, S Rajagopal

Citations: 19

9. Dissecting the cohesiveness among aromatics, saturates and structural features of aromatics towards needle coke generation in DCU from clarified oil by analytical techniques

Authors: S Mondal, A Yadav, V Pandey, V Sugumaran, R Bagai, R Kumar, …

Citations: 13

10. Process for simultaneous cracking of lighter and heavier hydrocarbon feed and system for the same

Authors: S Subramani, D Bhattacharyya, R Manna, SK Das, T Sarkar, S Rajagopal

Citations: 13

11. Process for the production of needle coke

Authors: D Bhattacharyya, SV Kumaran, BVHP Gupta, P Kumar, AK Das, G Saidulu, …

Citations: 8

12. Delayed coker drum and method of operating thereof

Authors: THVD Prasad, PR Pradeep, SK Das, JK Dixit, G Thapa, D Bhattacharyya, …

Citations: 7